59 results
Page 2 of 3
8-K
EX-99.1
l40v1d9dlpxyj01w5
22 Jan 19
Millendo Therapeutics Reports Inducement Grants
5:17pm
DEFM14A
4441fzoneh1ho2k
6 Nov 18
Proxy related to merger
12:00am
424B3
kud3up7g3dacl74qfp
5 Nov 18
Prospectus supplement
3:51pm
S-4/A
zivtfjg
1 Nov 18
Registration of securities issued in business combination transactions (amended)
5:32pm
8-K
EX-2.1
kqqs9gjz
9 Aug 18
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
5:19pm
8-K
EX-99.2
t15l j54mxr403vi
9 Aug 18
OvaScience and Millendo Therapeutics Announce Merger to Create Leading Rare Endocrine Disease Company
5:19pm
425
EX-2.1
yw1by 0aw
9 Aug 18
Business combination disclosure
5:17pm
425
EX-99.2
7r9cxkh 6j968b
9 Aug 18
Business combination disclosure
5:17pm